Product Review: Febuxostat in Gout

In this review:

This review is a summary of evidence for febuxostat (Adenuric®) as urate-lowering therapy for the treatment of gout. Febuxostat is an orally-administered xanthine oxidase inhibitor that blocks the production of urate. Febuxostat is indicated for the treatment of chronic hyperuricaemia in adults with gout (including a history, or presence of, tophus and/or gouty arthritis).

Please login below to download this issue (PDF)

Subscribe